Search
- Page Path
-
HOME
> Search
Case Report
- A Case of Hepatocellular Carcinoma which Showed Response to Transarterial Chemoembolization with DC Bead® in the Patient who Showed No Response to Conventional Transarterial Chemoembolization
-
Do Seon Song, Hee Yeon Kim, Myeong Jun Song, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Ho Jong Chun
-
Journal of the Korean Liver Cancer Study Group. 2012;12(2):133-136. Published online September 30, 2012
-
-
-
Abstract
PDF
- Hepatocellular carcinoma (HCC) is one of the most important cause of cancer death in South Korea. Approximately two thirds
of the HCC patients are diagnosed in the unresectable stage. Conventional transarterial chemoembolization (TACE) showed
survival benefit in the unresectable HCC patients, but it had some limitations, such as low response rate and systemic toxicity.
Drug eluting bead has been reported low systemic toxicity and higher tumor necrosis rate. We report a case which showed
response to TACE with DC bead in patient that showed no response to conventional TACE.
TOP